Paediatric Respiratory Reviews
Volume 11, Issue 3 , Pages 171-176 , September 2010

Acute lung injury in the child

  • Jonathan Egan

      Affiliations

    • Corresponding Author InformationLocked Bag 4001, Westmead 2145, New South Wales, Australia. Tel.: +61 2 9845 1988; Fax: +61 2 9845 1993.

References 

  1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2:319–323
  2. Petty TL, Ashbaugh DG. The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. Chest. 1971;60:233–239
  3. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS, Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–824
  4. Numa AH. Acute lung injury: outcomes and new therapies. Paediatr Respir Rev. 2001;2:22–31
  5. Dahlem P, van Aalderen WM, Hamaker ME, Dijkgraaf MG, Bos AP. Incidence and short-term outcome of acute lung injury in mechanically ventilated children. Eur Respir J. 2003;22:980–985
  6. Erickson S, Schibler A, Numa A, Nuthall G, Yung M, Pascoe E, et al. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study. Pediatr Crit Care Med. 2007;8:317–323
  7. Zimmerman JJ, Akhtar SR, Caldwell E, Rubenfeld GD. Incidence and outcomes of pediatric acute lung injury. Pediatrics. 2009;124:87–95
  8. Flori HR, Glidden DV, Rutherford GW, Matthay MA. Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med. 2005;171:995–1001
  9. Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. Jama. 2005;293:470–476
  10. Holbrook PR, Taylor G, Pollack MM, Fields AI. Adult respiratory distress syndrome in children. Pediatr Clin North Am. 1980;27:677–685
  11. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671–1684
  12. Williams S, Horrocks IA, Ouvrier RA, Gillis J, Ryan MM. Critical illness polyneuropathy and myopathy in pediatric intensive care: A review. Pediatr Crit Care Med. 2007;8:18–22
  13. Hammer J. ARDS--long term follow up. Paediatr Respir Rev. 2006;7(Suppl 1):S192–S193
  14. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–1349
  15. Gattinoni L, Pelosi P, Suter PM, Pedoto A, Vercesi P, Lissoni A. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?. Am J Respir Crit Care Med. 1998;158:3–11
  16. Albuali WH, Singh RN, Fraser DD, Seabrook JA, Kavanagh BP, Parshuram CS, et al. Have changes in ventilation practice improved outcome in children with acute lung injury?. Pediatr Crit Care Med. 2007;8:324–330
  17. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301–8.
  18. Nichols DG, Rogers MC. Rogers’ textbook of pediatric intensive care. 4th ed.. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;
  19. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 2001;344:481–487
  20. Essouri S, Chevret L, Durand P, Haas V, Fauroux B, Devictor D. Noninvasive positive pressure ventilation: five years of experience in a pediatric intensive care unit. Pediatr Crit Care Med. 2006;7:329–334
  21. Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med. 1990;16:372–377
  22. Khemani RG, Conti D, Alonzo TA, Bart RD, Newth CJ. Effect of tidal volume in children with acute hypoxemic respiratory failure. Intensive Care Med. 2009;35:1428–1437
  23. Stock MC, Downs JB, Frolicher DA. Airway pressure release ventilation. Crit Care Med. 1987;15:462–466
  24. Krishnan J, Morrison W. Airway pressure release ventilation: a pediatric case series. Pediatr Pulmonol. 2007;42:83–88
  25. Frawley PM, Habashi NM. Airway pressure release ventilation and pediatrics: theory and practice. Crit Care Nurs Clin North Am. 2004;16:337–348viii
  26. Arnold JH, Anas NG, Luckett P, Cheifetz IM, Reyes G, Newth CJ, et al. High-frequency oscillatory ventilation in pediatric respiratory failure: a multicenter experience. Crit Care Med. 2000;28:3913–3919
  27. Kissoon N, Rimensberger PC, Bohn D. Ventilation strategies and adjunctive therapy in severe lung disease. Pediatr Clin North Am. 2008;55:709–733xii
  28. Furchgott RF. Endothelium-derived relaxing factor: discovery, early studies and identification as nitric oxide: Nobel lecture, December 8, 1998; 1999.
  29. de Mol AC, van Heijst AF, Brouwers M, de Haan TF, van der Staak FH, Liem KD. Abnormalities of coagulation related to the use of inhaled nitric oxide before extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2007;8:261–263
  30. Namachivayam P, Theilen U, Butt WW, Cooper SM, Penny DJ, Shekerdemian LS. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med. 2006;174:1042–1047
  31. Adhikari NK, Burns KE, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. Bmj. 2007;334:779
  32. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2009;37:1594–1603
  33. Randolph AG. Management of acute lung injury and acute respiratory distress syndrome in children. Crit Care Med. 2009;37:2448–2454
  34. Kesecioglu J, Beale R, Stewart TE, Findlay GP, Rouby JJ, Holzapfel L, et al. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2009;180:989–994
  35. Curley MA, Hibberd PL, Fineman LD, Wypij D, Shih MC, Thompson JE, et al. Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA. 2005;294:229–237
  36. Church GD, Matthay MA, Liu K, Milet M, Flori HR. Blood product transfusions and clinical outcomes in pediatric patients with acute lung injury. Pediatr Crit Care Med. 2009;10:297–302
  37. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med. 2006;173:281–287
  38. Medford AR, Millar AB. Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?. Thorax. 2006;61:621–626
  39. Medford AR, Douglas SK, Godinho SI, Uppington KM, Armstrong L, Gillespie KM, et al. Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury. Respir Res. 2009;10:27
  40. Torii K, Iida K, Miyazaki Y, Saga S, Kondoh Y, Taniguchi H, et al. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med. 1997;155:43–46
  41. Kong MY, Gaggar A, Li Y, Winkler M, Blalock JE, Clancy JP. Matrix metalloproteinase activity in pediatric acute lung injury. Int J Med Sci. 2009;6:9–17
  42. O’Kane CM, McKeown SW, Perkins GD, Bassford CR, Gao F, Thickett DR, et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med. 2009;37:2242–2249
  43. Fahy RJ, Lichtenberger F, McKeegan CB, Nuovo GJ, Marsh CB, Wewers MD. The acute respiratory distress syndrome: a role for transforming growth factor-beta 1. Am J Respir Cell Mol Biol. 2003;28:499–503
  44. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, et al. Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2004;286:L156–L164
  45. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax. 2008;63:1083–1089
  46. Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med. 1998;158:1432–1441
  47. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, et al. Prognostic and Pathogenetic Value of Combining Clinical and Biochemical Indices in Patients with Acute Lung Injury. Chest. 2009;
  48. Schibler A, Yuill M, Parsley C, Pham T, Gilshenan K, Dakin C. Regional ventilation distribution in non-sedated spontaneously breathing newborns and adults is not different. Pediatr Pulmonol. 2009;44:851–858
  49. Samara Z, Raux M, Fiamma MN, Gharbi A, Gottfried SB, Poon CS, et al. Effects of inspiratory loading on the chaotic dynamics of ventilatory flow in humans. Respir Physiol Neurobiol. 2009;165:82–89
  50. Randolph AG, Meert KL, O’Neil ME, Hanson JH, Luckett PM, Arnold JH, et al. The feasibility of conducting clinical trials in infants and children with acute respiratory failure. Am J Respir Crit Care Med. 2003;167:1334–1340

PII: S1526-0542(10)00023-0

doi: 10.1016/j.prrv.2010.03.001

Paediatric Respiratory Reviews
Volume 11, Issue 3 , Pages 171-176 , September 2010

Article Tools